Results 21 to 30 of about 1,218,098 (252)

Arterial Hypertension

open access: yes, 2022
Hypertension is a complex, multifactorial and multisystem disorder and a leading cause of morbidity and premature death globally. Major guidelines define it as systolic blood pressure > 130 mmHg and/or diastolic blood pressure > 80 mmHg. Hypertension is a very common disease with prevalence rates of about 30% in adults worldwide.
Touyz, Rhian M.   +10 more
openaire   +3 more sources

Dietary sodium sources in hypertensive patients

open access: yesArterial Hypertension, 2023
BACKGROUND: Reducing dietary salt intake is the method recommended by the experts as the non-pharmacological treatment of hypertension. The purpose of this study was to evaluate the amount of dietary sodium intake by hypertensive patients and to analyze ...
Dariusz Stąpor   +5 more
doaj   +1 more source

Unattended automated office blood pressure measurement — current evidence and the role in clinical practice

open access: yesArterial Hypertension, 2021
Arterial hypertension is a leading preventable cardiovascular risk factor. The definition and thresholds for the diagnosis of hypertension vary between European and American guidelines.
Marek Stopa   +2 more
doaj   +1 more source

PULMONARY ARTERIAL HYPERTENSION

open access: yesAnnals of Medicine, 2006
Pulmonary arterial hypertension is a disease of the small pulmonary arteries characterized by vascular narrowing and increased pulmonary vascular resistance, which eventually leads to right ventricular failure. Vasoconstriction, vascular proliferation, remodeling of the pulmonary vessels, and thrombosis are all contributing factors to the increased ...
Azad, Raiesdana, Joseph, Loscalzo
  +7 more sources

Myocardial infarction caused by Graves’ disease

open access: yesEndokrynologia Polska, 2021
Not required for Clinical Vignette.
Marek Kuch   +3 more
doaj   +1 more source

Exploratory analysis of the neutrophil to lymphocyte ratio in patients with pulmonary arterial hypertension

open access: yesBMC Pulmonary Medicine, 2017
Background Chronic inflammation emerges as a feature of the pathogenesis of pulmonary arterial hypertension (PAH) in experimental models. Alterations of circulating cell subsets have been observed in patients with PAH.
Lars Harbaum   +9 more
doaj   +1 more source

Prevalence and clinical implications of atrial fibrillation in patients hospitalized due to COVID-19: Data from a registry in Poland

open access: yesFrontiers in Cardiovascular Medicine, 2023
BackgroundAtrial fibrillation (AF) is a common arrhythmia with increasing prevalence with respect to age and comorbidities. AF may influence the prognosis in patients hospitalized with Coronavirus disease 2019 (COVID-19).
Michał Terlecki   +15 more
doaj   +1 more source

Transforming growth factor-beta receptor mutations and pulmonary arterial hypertension in childhood [PDF]

open access: yes, 2005
BACKGROUND: Pulmonary arterial hypertension (PAH) is a potentially fatal vasculopathy that can develop at any age. Adult-onset disease has previously been associated with mutations in BMPR2 and ALK-1.
Haworth, SG   +22 more
core   +1 more source

Resistant hypertension after renal infarction in a man with fibromuscular dysplasia

open access: yesBlood Pressure, 2021
We report the case of 39-year-old Caucasian man presenting in emergency department with new onset of severe hypertension with hypokalaemia eight weeks after renal colic. Patient was referred to a hypertension unit for further investigation.
Nikolina Bukal   +4 more
doaj   +1 more source

Clinical phenotyping of plasma thrombospondin-2 reveals relationship to right ventricular structure and function in pulmonary hypertension

open access: yesERJ Open Research, 2023
Background Converging evidence from proteogenomic analyses prioritises thrombospondin-2 (TSP2) as a potential biomarker for idiopathic or heritable pulmonary arterial hypertension (PAH).
Anna M. Dittrich   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy